Is Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Rhythm Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Rhythm Pharmaceuticals Inc. is $3.23B. A total of 0.63 million shares were traded on the day, compared to an average of 491.26K shares.

In the most recent transaction, GOOD JENNIFER L sold 31,751 shares of RYTM for 52.40 per share on Sep 17 ’24. After the transaction, the Director now owns 3,000 company shares. In a previous transaction on Sep 17 ’24, JENNIFER GOOD bought 31,751 shares at 49.52 per share.

Among the insiders who sold shares, Cramer Pamela J. disposed of 4,099 shares on Sep 09 ’24 at a per-share price of $50.03. This resulted in the Chief Human Resources Officer holding 13,500 shares of RYTM after the transaction. In another insider transaction, TETRAULT LYNN A. sold 17,501 shares at $49.65 per share on Sep 10 ’24. Company shares held by the Director now total 3,000.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RYTM has a high of $55.64 and a low of $20.97.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RYTM’s latest balance sheet shows that the firm has $294.86M in Cash & Short Term Investments as of fiscal 2021. There were $2.55M in debt and $43.43M in liabilities at the time. Its Book Value Per Share was $0.64, while its Total Shareholder’s Equity was $284.15M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RYTM is Buy with a score of 4.70.

Most Popular

Related Posts